Patent · US Active

Paratope and epitope of anti-mortalin antibody

US8591893B2 · kind B2 · utility

4Cited by
1References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 2008
Grant dateNov 26, 2013
Priority date
Expiry dateApr 8, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/10
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The amino acid sequences of paratope regions involved in internalizing function of an anti-mortalin antibody into tumor cells were determined for the L-chain and H-chain variable regions of cellular internalizing anti-mortalin antibodies and non-internalizing anti-mortalin antibodies. Cancer-cell-specific drug delivery is provided by using the mortalin-binding activity of a single-chain antibody (scFv) wherein L-chain and H-chain variable regions both having the paratope region are linked together via a peptide linker. Also, the sequence of 6 amino acids of an epitope to be recognized by an anti-mortalin antibody having the internalizing function was determined. With the use of an expression vector comprising a nucleic acid that encodes the epitope, an agent for accelerating internalization of a mortalin antibody, a drug bound thereto, and the like into cancer cells is provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.